tor generics limited
tor generics limited Company Information
Company Number
04429935
Next Accounts
Feb 2026
Directors
Shareholders
alison winifred irene stevenson
Group Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
the tudor house northgate, northwood, middlesex, HA6 2TH
Website
www.tor-generics.comtor generics limited Estimated Valuation
Pomanda estimates the enterprise value of TOR GENERICS LIMITED at £564.6k based on a Turnover of £1.2m and 0.48x industry multiple (adjusted for size and gross margin).
tor generics limited Estimated Valuation
Pomanda estimates the enterprise value of TOR GENERICS LIMITED at £2.6m based on an EBITDA of £539.6k and a 4.76x industry multiple (adjusted for size and gross margin).
tor generics limited Estimated Valuation
Pomanda estimates the enterprise value of TOR GENERICS LIMITED at £6.3m based on Net Assets of £3.3m and 1.91x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Tor Generics Limited Overview
Tor Generics Limited is a live company located in middlesex, HA6 2TH with a Companies House number of 04429935. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in May 2002, it's largest shareholder is alison winifred irene stevenson with a 100% stake. Tor Generics Limited is a mature, small sized company, Pomanda has estimated its turnover at £1.2m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Tor Generics Limited Health Check
Pomanda's financial health check has awarded Tor Generics Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
4 Weak
Size
annual sales of £1.2m, make it smaller than the average company (£25.3m)
- Tor Generics Limited
£25.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 17%, show it is growing at a faster rate (5.6%)
- Tor Generics Limited
5.6% - Industry AVG
Production
with a gross margin of 28%, this company has a comparable cost of product (28%)
- Tor Generics Limited
28% - Industry AVG
Profitability
an operating margin of 45.7% make it more profitable than the average company (4%)
- Tor Generics Limited
4% - Industry AVG
Employees
with 1 employees, this is below the industry average (37)
1 - Tor Generics Limited
37 - Industry AVG
Pay Structure
on an average salary of £79.7k, the company has an equivalent pay structure (£79.7k)
- Tor Generics Limited
£79.7k - Industry AVG
Efficiency
resulting in sales per employee of £1.2m, this is more efficient (£664.6k)
- Tor Generics Limited
£664.6k - Industry AVG
Debtor Days
it gets paid by customers after 113 days, this is later than average (59 days)
- Tor Generics Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 23 days, this is quicker than average (28 days)
- Tor Generics Limited
28 days - Industry AVG
Stock Days
it holds stock equivalent to 53 days, this is less than average (68 days)
- Tor Generics Limited
68 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 550 weeks, this is more cash available to meet short term requirements (13 weeks)
550 weeks - Tor Generics Limited
13 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 8%, this is a lower level of debt than the average (51.8%)
8% - Tor Generics Limited
51.8% - Industry AVG
TOR GENERICS LIMITED financials
Tor Generics Limited's latest turnover from May 2024 is estimated at £1.2 million and the company has net assets of £3.3 million. According to their latest financial statements, Tor Generics Limited has 1 employee and maintains cash reserves of £3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 1 | 2 | 3 | 2 | 1 | 3 | 4 | 1 | 3 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 915 | 1,143 | 1,523 | 1,903 | 2,378 | 3,270 | 4,112 | 4,726 | 173 | 392 | 1,209 | 1,996 | 3,421 | 8,607 | |
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 915 | 1,143 | 1,523 | 1,903 | 2,378 | 3,270 | 4,112 | 4,726 | 173 | 392 | 1,209 | 1,996 | 3,421 | 8,607 | |
| Stock & work in progress | 125,009 | 142,109 | 69,060 | 145,694 | 206,355 | 59,830 | 230,802 | 80,256 | 33,793 | 55,760 | 29,128 | 8,400 | 17,181 | ||
| Trade Debtors | 366,833 | 168,986 | 124,866 | 121,307 | 45,243 | 68,800 | 70,288 | 115,498 | 226,093 | 473,342 | 310,152 | 266,822 | 166,520 | 54,140 | 515,867 |
| Group Debtors | |||||||||||||||
| Misc Debtors | 12,875 | 5,000 | 6,896 | 6,896 | 6,896 | 56,777 | 6,896 | 6,296 | 89,005 | 163,173 | 171,155 | ||||
| Cash | 3,037,485 | 2,558,783 | 1,947,200 | 1,624,830 | 1,615,973 | 1,681,165 | 1,578,736 | 1,673,337 | 1,982,152 | 229,249 | 98,592 | 22,526 | 3,099 | 56,339 | 41,987 |
| misc current assets | 27,692 | 47,777 | 22,181 | ||||||||||||
| total current assets | 3,569,894 | 2,922,655 | 2,148,022 | 1,898,727 | 1,874,467 | 1,866,572 | 1,886,722 | 1,897,568 | 2,331,043 | 758,351 | 437,872 | 297,748 | 349,973 | 281,634 | 557,854 |
| total assets | 3,569,894 | 2,923,570 | 2,149,165 | 1,900,250 | 1,876,370 | 1,868,950 | 1,889,992 | 1,901,680 | 2,335,769 | 758,524 | 438,264 | 298,957 | 351,969 | 285,055 | 566,461 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 54,868 | 33,082 | 38,665 | 37,270 | 34,780 | 50,016 | 46,632 | 77,064 | 107,803 | 450,486 | 134,465 | 151,927 | 238,087 | 271,742 | |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 232,060 | 122,394 | 44,708 | 35,434 | 32,191 | 28,323 | 16,501 | 15,082 | 578,529 | ||||||
| total current liabilities | 286,928 | 155,476 | 83,373 | 72,704 | 66,971 | 78,339 | 63,133 | 92,146 | 686,332 | 450,486 | 134,465 | 151,927 | 238,087 | 271,742 | |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | 150,253 | ||||||||||||||
| provisions | 61,074 | 693 | |||||||||||||
| total long term liabilities | 61,074 | 150,253 | 693 | ||||||||||||
| total liabilities | 286,928 | 155,476 | 83,373 | 72,704 | 66,971 | 78,339 | 63,133 | 92,146 | 686,332 | 450,486 | 195,539 | 151,927 | 238,087 | 150,253 | 272,435 |
| net assets | 3,282,966 | 2,768,094 | 2,065,792 | 1,827,546 | 1,809,399 | 1,790,611 | 1,826,859 | 1,809,534 | 1,649,437 | 308,038 | 242,725 | 147,030 | 113,882 | 134,802 | 294,026 |
| total shareholders funds | 3,282,966 | 2,768,094 | 2,065,792 | 1,827,546 | 1,809,399 | 1,790,611 | 1,826,859 | 1,809,534 | 1,649,437 | 308,038 | 242,725 | 147,030 | 113,882 | 134,802 | 294,026 |
| May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 228 | 1,021 | 380 | 475 | 3,623 | 842 | 1,112 | 1,246 | 219 | 817 | 1,214 | 2,008 | 5,843 | 5,846 | |
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | -17,100 | 73,049 | -76,634 | -60,661 | 146,525 | -170,972 | 150,546 | 46,463 | -21,967 | 26,632 | 20,728 | -8,781 | 17,181 | ||
| Debtors | 205,722 | 42,224 | 3,559 | 76,064 | -73,438 | 48,393 | -44,610 | -193,304 | -158,244 | 163,190 | 43,330 | -62,871 | 104,398 | -290,572 | 515,867 |
| Creditors | 21,786 | -5,583 | 1,395 | 2,490 | -15,236 | 3,384 | -30,432 | -30,739 | -342,683 | 316,021 | -17,462 | -86,160 | 238,087 | -271,742 | 271,742 |
| Accruals and Deferred Income | 109,666 | 77,686 | 9,274 | 3,243 | 3,868 | 11,822 | 1,419 | -563,447 | 578,529 | ||||||
| Deferred Taxes & Provisions | -61,074 | 61,074 | -693 | 693 | |||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | -150,253 | 150,253 | |||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 478,702 | 611,583 | 322,370 | 8,857 | -65,192 | 102,429 | -94,601 | -308,815 | 1,752,903 | 130,657 | 76,066 | 19,427 | -53,240 | 14,352 | 41,987 |
| overdraft | |||||||||||||||
| change in cash | 478,702 | 611,583 | 322,370 | 8,857 | -65,192 | 102,429 | -94,601 | -308,815 | 1,752,903 | 130,657 | 76,066 | 19,427 | -53,240 | 14,352 | 41,987 |
tor generics limited Credit Report and Business Information
Tor Generics Limited Competitor Analysis
Perform a competitor analysis for tor generics limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HA6 area or any other competitors across 12 key performance metrics.
tor generics limited Ownership
TOR GENERICS LIMITED group structure
Tor Generics Limited has no subsidiary companies.
Ultimate parent company
TOR GENERICS LIMITED
04429935
tor generics limited directors
Tor Generics Limited currently has 1 director, Ms Alison Stevenson serving since May 2002.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Alison Stevenson | United Kingdom | 61 years | May 2002 | - | Director |
P&L
May 2024turnover
1.2m
+36%
operating profit
539.6k
0%
gross margin
28.1%
-0.87%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2024net assets
3.3m
+0.19%
total assets
3.6m
+0.22%
cash
3m
+0.19%
net assets
Total assets minus all liabilities
tor generics limited company details
company number
04429935
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
May 2002
age
23
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
May 2024
previous names
N/A
accountant
-
auditor
-
address
the tudor house northgate, northwood, middlesex, HA6 2TH
Bank
-
Legal Advisor
-
tor generics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to tor generics limited.
tor generics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for TOR GENERICS LIMITED. This can take several minutes, an email will notify you when this has completed.
tor generics limited Companies House Filings - See Documents
| date | description | view/download |
|---|
